| Old Articles: <Older 3191-3200 Newer> |
 |
BusinessWeek October 23, 2006 Weintraub & Barrett |
Medicine In Conflict There is more concern than ever that doctors are blurring the lines between objective science and financial gain.  |
BusinessWeek October 23, 2006 Arlene Weintraub |
How The Journals Are Cracking Down With concerns about conflicts of interest on the rise, many medical journals are cracking down.  |
BusinessWeek October 23, 2006 Arlene Weintraub |
"Disclosure Is A Lousy Solution" Even as disclosure has emerged as the all-purpose solution for financial conflicts of interest in medicine, recent research suggests that the practice may exacerbate the problem.  |
BusinessWeek October 23, 2006 Arlene Weintraub |
Cracking Down on Pharma Swag Several medical centers are barring their doctors from accepting freebies like pens and lunches from any vendor. Here's why.  |
Pharmaceutical Executive October 1, 2006 Joanna Breitstein |
"I Pray for the Welfare of Your Company..." Big Pharma's drugs fill Teva Pharmaceutical's pipeline. CEO Israel Makov says he's not the enemy. To prove it, he offers lessons in survival.  |
Pharmaceutical Executive October 1, 2006 Albert & Sass |
A Survey of Medical Science Liaisons Who are those accomplished people hobnobbing with medicine's best and brightest? And what is it they like about their jobs?  |
Pharmaceutical Executive October 1, 2006 Beth Herskovits |
Born Again Mifepristone is best known as an abortion drug. But it appears to be on the verge of a second career - treating a severe form of major depression.  |
Pharmaceutical Executive October 1, 2006 Jason McKinnie |
Smaller is Better Everybody has heard about using nanotechnology in drug delivery, but not many people - even specialists in drug development - know quite where the new technology fits in.  |
Pharmaceutical Executive October 1, 2006 |
Sales and Marketing: Where the Buck Stops Pharma's ultimate customer is the employer - the guy who pays the health plan's bill. Here's what he wants to know about drugs.  |
Pharmaceutical Executive October 1, 2006 Ray Hill |
China: Big Rewards. Bigger Risks? The world's fastest growing pharmaceutical market may one day be the largest. Breaking in could be industry's greatest challenge.  |
| <Older 3191-3200 Newer> Return to current articles. |